Skip to main content



  • Tuesday, Jul 15th
    2:00 PM - 4:00 PM EDT
    Tech Session II: Oral Delivery I
    Location: 124
    Chair: Katie Whitehead, PhD (she/her/hers) – Carnegie Mellon University
    Co-Chair: Matteo Tollemeto (he/him/his) – Technical University of Denmark
    Oral Delivery
  • Tuesday, Jul 15th
    2:04 PM - 2:29 PM EDT
    A model-informed drug development (MIDD) approach to designing modified release formulations for a BCS Class I drug
    Location: 124
    Invited Speaker: John P. Gleeson, PhD (he/him/his) – Merck & Co.
    Oral Delivery
  • Tuesday, Jul 15th
    2:29 PM - 2:54 PM EDT
    Development of a Novel Antibody-Based Oral Factor VIII Mimetic Drug Candidate (Inno8)
    Location: 124
    Invited Speaker - Exceptional Abstract: Philip Jonas Sassene, n/a (he/him/his) – Novo Nordisk
    Oral Delivery
  • Tuesday, Jul 15th
    2:54 PM - 3:05 PM EDT
    Oral Protein Delivery: Nanoassemblies for Targeted Treatment of Intestinal Diseases
    Location: 124
    Oral Abstract Speaker: María González Portela, PhD candidate in Pharmacy (she/her/hers) – CiMUS (University of Santiago de Compostela)
    Oral Delivery
  • Tuesday, Jul 15th
    3:05 PM - 3:16 PM EDT
    Formulating Biologics for Buccal Delivery: An Investigation of Feasibility and Stability
    Location: 124
    Oral Abstract Speaker: Anthony Rajabi, MPharm – Aston University
    Oral Delivery
  • Tuesday, Jul 15th
    3:16 PM - 3:27 PM EDT
    Fabrication of 3D-printed chewable tablets using hot melt extrusion coupled with direct extrusion
    Location: 124
    Oral Abstract Speaker: Siva Satyanarayana Kolipaka, Student Status Letter_ University of Greenwich – University of Greenwich
    Oral Delivery
  • Tuesday, Jul 15th
    3:38 PM - 3:49 PM EDT
    Optimizing Leuprorelin-Permeability Enhancer Complexes for Oral Release
    Location: 124
    Oral Abstract Speaker: Deborah E. Shalev, PhD (she/her/hers) – Azrieli College of Engineering Jerusalem
    Oral Delivery
  • Tuesday, Jul 15th
    3:49 PM - 4:00 PM EDT
    Precision nanomedicine for pediatric oral drug delivery in infectious diseases
    Location: 124
    Local Chapter Speaker: Jonathan T. Chanyandura, Masters of Pharmacy, Bachelor of Pharmacy (he/him/his) – University of the Witwatersrand
    Oral Delivery
  • Wednesday, Jul 16th
    2:00 PM - 4:00 PM EDT
    Tech Session IV: Oral Delivery II
    Location: 124
    Chair: Amirali Popat – School of Pharmacy, The University of Queensland
    Co-Chair: Marwa Sallam, PhD (she/her/hers) – school of Engineering, Brown University
    Oral Delivery
  • Wednesday, Jul 16th
    2:04 PM - 2:29 PM EDT
    Transbuccal delivery of peptides with the suction patch
    Location: 124
    Invited Speaker: Jean-Christophe Leroux, PhD (he/him/his) – ETH Zurich
    Oral Delivery
  • Wednesday, Jul 16th
    2:29 PM - 2:54 PM EDT
    Hemi-porous Janus microparticles as a muco-adhesive enteral delivery system for BCS Class III drugs
    Location: 124
    Invited Speaker - Exceptional Abstract: Akihiro Matsumoto, PhD – Osaka Ohtani University
    Oral Delivery
  • Wednesday, Jul 16th
    2:54 PM - 3:05 PM EDT
    An innovative inflammation-targeting platform for ulcerative colitis treatment
    Location: 124
    Oral Abstract Speaker: Waliul Islam, PhD – Johns Hopkins University School of Medicine
    Oral Delivery
  • Wednesday, Jul 16th
    3:05 PM - 3:16 PM EDT
    Reduced griseofulvin permeation across a hollow fiber membrane due to drug micellization
    Location: 124
    Oral Abstract Speaker: Roshni P. Patel, Master of Science – University of Maryland, Baltimore
    Oral Delivery
  • Wednesday, Jul 16th
    3:16 PM - 3:27 PM EDT
    Evaluation of Acid-Base Supersolubilization Principle on Telmisartan to Lower HME Temperature
    Location: 124
    Oral Abstract Speaker: Mohammed I. Syed, PhD – Evonik Corporation, St. Johns University
    Oral Delivery
  • Wednesday, Jul 16th
    3:27 PM - 3:38 PM EDT
    An antioxidant MOF with functional coatings for oral antibody delivery in inflammatory bowel disease
    Location: 124
    Oral Abstract Speaker: Cheng Chen, MA (she/her/hers) – Université catholique de Louvain
    Oral Delivery
  • Wednesday, Jul 16th
    3:38 PM - 3:49 PM EDT
    Lipid Formulations in Customized Enteric Capsules Show Promising Results For Oral GLP-1 RA Delivery
    Location: 124
    Oral Abstract Speaker: Vincent Jannin, PhD – Capsugel France SAS / Lonza
    Oral Delivery
  • Wednesday, Jul 16th
    3:49 PM - 4:00 PM EDT
    Tips and tricks for increasing oral drug absorption from nanoemulsions
    Location: 124
    Local Chapter Speaker: Anette Müllertz, PhD (she/her/hers) – University of Copenhagen
    Oral Delivery
  • Thursday, Jul 17th
    10:00 AM - 12:00 PM EDT
    Tech Session V: Nanomedicine and Nanoscale Delivery (Focus: Oral)
    Location: 121 B/C
    Chair: Stefano Salmaso, PhD (he/him/his) – University of Padova
    Co-Chair: Yahya E. Choonara, BPharm, MPharm, PhD (he/him/his) – University of the Witwatersrand
    Nanomedicine and Nanoscale DeliveryOral Delivery
  • Thursday, Jul 17th
    10:04 AM - 10:29 AM EDT
    Magneto-responsive drug delivery systems for local treatment of colorectal cancer
    Location: 121 B/C
    Invited Speaker: Alexandra Teleki, PhD (she/her/hers) – Uppsala University
    Nanomedicine and Nanoscale DeliveryOral Delivery
  • Thursday, Jul 17th
    10:29 AM - 10:54 AM EDT
    NAC-based Ionic Liquids for GLP-1 Delivery: A Mechanistic Understanding of In Vivo Performance
    Location: 121 B/C
    Invited Speaker - Exceptional Abstract: Zhigao Niu (he/him/his) – Novo Nordisk
    Nanomedicine and Nanoscale DeliveryOral Delivery
  • Thursday, Jul 17th
    10:54 AM - 11:05 AM EDT
    Intestinal Fc receptor-targeted nanomedicines boost semaglutide effect in type 2 diabetes
    Location: 121 B/C
    Oral Abstract Speaker: Soraia FT Pinto, PhD (she/her/hers) – Institute for Research and Innovation in Health (i3S), University of Porto, Portugal
    Nanomedicine and Nanoscale DeliveryOral Delivery
  • Thursday, Jul 17th
    11:05 AM - 11:16 AM EDT
    Oral delivery of MSC-EVs as a novel approach to treat inflammatory bowel disease
    Location: 121 B/C
    Oral Abstract Speaker: Mona Belaid (she/her/hers) – King's College London and National University of Singapore
    Nanomedicine and Nanoscale DeliveryOral Delivery
  • Thursday, Jul 17th
    11:16 AM - 11:27 AM EDT
    Predicting Drug Delivery of Push Pull OROS: A Biorelevant Dissolution and PK Simulation Strategy
    Location: 121 B/C
    Oral Abstract Speaker: Grzegorz Z. Garbacz, g.garbacz@physiolution.pl (he/him/his) – Physiolution
    Nanomedicine and Nanoscale DeliveryOral Delivery
  • Thursday, Jul 17th
    11:38 AM - 11:49 AM EDT
    Transforming Healthcare: Treatment of Inflammatory Bowel Disease with Biocatalytic Nanobots
    Location: 121 B/C
    Oral Abstract Speaker: Ana Sofia Sousa, MSc (she/her/hers) – Universidade Católica Portuguesa
    Nanomedicine and Nanoscale DeliveryOral Delivery
  • Thursday, Jul 17th
    11:49 AM - 12:00 PM EDT
    Improving bioavailability of poorly soluble oral drugs
    Location: 121 B/C
    Oral Abstract Speaker: Taslima Binte Kamal – University of New South Wales
    Nanomedicine and Nanoscale DeliveryOral Delivery
  • Thursday, Jul 17th
    4:30 PM - 6:30 PM EDT
    Tech Session VI: Oral Delivery III
    Location: 125
    Chair: Ana Beloqui, PhD (she/her/hers) – Université catholique de Louvain
    Co-Chair: Davide Brambilla, PhD (he/him/his) – Université de Montreal
    Oral Delivery
  • Thursday, Jul 17th
    4:34 PM - 4:59 PM EDT
    Invited Speaker Presentation I
    Location: 125
    Invited Speaker: Giovanni Traverso, MB, BChir, PhD – MIT, Harvard Medical School
    Oral Delivery
  • Thursday, Jul 17th
    4:59 PM - 5:24 PM EDT
    Engineering Nanotherapeutics for Local Intestinal Delivery Responding to Oxidative Cues in the Gut Microenvironment
    Location: 125
    Invited Speaker: Bruno Sarmento, PhD (he/him/his) – i3S . Instituto de Investigação e Inovação em Saúde, University of Porto
    Oral Delivery
  • Thursday, Jul 17th
    5:24 PM - 5:35 PM EDT
    3D Printed Ileum Targeted Tablet for the Treatment of IgA Nephropathy
    Location: 125
    Oral Abstract Speaker: Xiaoling Li, PhD – Thomas J. Long School of Pharmacy at the University of the Pacific
    Oral Delivery
  • Thursday, Jul 17th
    5:35 PM - 5:46 PM EDT
    Orally administered macrophage targeted dendrimer-Tesaglitazar for obesity and atherosclerosis
    Location: 125
    Oral Abstract Speaker: Jose Diego Almodiel – Johns Hopkins University
    Oral Delivery
  • Thursday, Jul 17th
    5:46 PM - 5:57 PM EDT
    Elucidation of Tablet Dissolution and Functional Excipient Behavior with In Situ Exposure Imaging
    Location: 125
    Oral Abstract Speaker: Andrew G. Clark, n/a (he/him/his) – digiM Solution
    Oral Delivery
  • Thursday, Jul 17th
    5:57 PM - 6:08 PM EDT
    A successful application of high-loading amorphous solid dispersions in HME & Additive Manufacturing
    Location: 125
    Oral Abstract Speaker: Carolina Alva – Research Center Pharmaceutical Engineering
    Oral Delivery
  • Thursday, Jul 17th
    6:08 PM - 6:19 PM EDT
    Mitochondria-targeted nitric oxide releasing graphene oxide for cardiovascular therapeutics
    Location: 125
    Oral Abstract Speaker: Tanveer Tabish, PhD – University of Oxford
    Oral Delivery
  • Thursday, Jul 17th
    6:19 PM - 6:30 PM EDT
    Increasing Efficacy - Decreasing Toxicity for a Given Dose Via Controlled Delivery
    Location: 125
    Oral Abstract Speaker: Leslie Z. Benet, PhD – UCSF
    Oral Delivery